questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérobicycliques
Benzofuranes
Benzofuranes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic and Statistical Manual of Mental Disorders
Diagnostic
5
Intoxication
Tests toxicologiques
Analyse de sang
Analyse d'urine
Symptômes
Troubles neurologiques
Tests de dépistage
Benzofuranes
Historique médical
Exposition
Symptômes
5
Effets psychologiques
Anxiété
Éruptions cutanées
Démangeaisons
Système respiratoire
Irritation
Prévention
5
Prévention
Équipements de protection
Mesures de sécurité
Laboratoire
Gestion des déchets
Déchets dangereux
Traitements
5
Intoxication
Soins symptomatiques
Symptômes neurologiques
Médicaments
Soins d'urgence
Exposition
Décontamination
Absorption
Complications
5
Complications
Neurologiques
Maladies chroniques
Exposition prolongée
Effets à long terme
Troubles cognitifs
Reproduction
Effets néfastes
Suivi médical
Complications
Facteurs de risque
5
Travailleurs
Produits chimiques
Produits chimiques
Médicaments
Antécédents médicaux
Maladies respiratoires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Benzofuranes : Questions médicales les plus fréquentes",
"headline": "Benzofuranes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Benzofuranes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-05",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Benzofuranes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétérobicycliques",
"url": "https://questionsmedicales.fr/mesh/D006574",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétérobicycliques",
"code": {
"@type": "MedicalCode",
"code": "D006574",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Amiodarone",
"alternateName": "Amiodarone",
"url": "https://questionsmedicales.fr/mesh/D000638",
"about": {
"@type": "MedicalCondition",
"name": "Amiodarone",
"code": {
"@type": "MedicalCode",
"code": "D000638",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.075"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dronédarone",
"alternateName": "Dronedarone",
"url": "https://questionsmedicales.fr/mesh/D000077764",
"about": {
"@type": "MedicalCondition",
"name": "Dronédarone",
"code": {
"@type": "MedicalCode",
"code": "D000077764",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.075.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Benzbromarone",
"alternateName": "Benzbromarone",
"url": "https://questionsmedicales.fr/mesh/D001553",
"about": {
"@type": "MedicalCondition",
"name": "Benzbromarone",
"code": {
"@type": "MedicalCode",
"code": "D001553",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.110"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cantharidine",
"alternateName": "Cantharidin",
"url": "https://questionsmedicales.fr/mesh/D002193",
"about": {
"@type": "MedicalCondition",
"name": "Cantharidine",
"code": {
"@type": "MedicalCode",
"code": "D002193",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.125"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Citalopram",
"alternateName": "Citalopram",
"url": "https://questionsmedicales.fr/mesh/D015283",
"about": {
"@type": "MedicalCondition",
"name": "Citalopram",
"code": {
"@type": "MedicalCode",
"code": "D015283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.187"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Escitalopram",
"alternateName": "Escitalopram",
"url": "https://questionsmedicales.fr/mesh/D000089983",
"about": {
"@type": "MedicalCondition",
"name": "Escitalopram",
"code": {
"@type": "MedicalCode",
"code": "D000089983",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.203"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fura-2",
"alternateName": "Fura-2",
"url": "https://questionsmedicales.fr/mesh/D016257",
"about": {
"@type": "MedicalCondition",
"name": "Fura-2",
"code": {
"@type": "MedicalCode",
"code": "D016257",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Griséofulvine",
"alternateName": "Griseofulvin",
"url": "https://questionsmedicales.fr/mesh/D006118",
"about": {
"@type": "MedicalCondition",
"name": "Griséofulvine",
"code": {
"@type": "MedicalCode",
"code": "D006118",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.275"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Benzofuranes",
"alternateName": "Benzofurans",
"code": {
"@type": "MedicalCode",
"code": "D001572",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Zhi Xu",
"url": "https://questionsmedicales.fr/author/Zhi%20Xu",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, Guizhou, P.R. China."
}
},
{
"@type": "Person",
"name": "Wei Zhou",
"url": "https://questionsmedicales.fr/author/Wei%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, Guizhou Medical University, Guiyang 550025, Guizhou, P.R. China."
}
},
{
"@type": "Person",
"name": "Ashraf A Abbas",
"url": "https://questionsmedicales.fr/author/Ashraf%20A%20Abbas",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602."
}
},
{
"@type": "Person",
"name": "Kamal M Dawood",
"url": "https://questionsmedicales.fr/author/Kamal%20M%20Dawood",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602."
}
},
{
"@type": "Person",
"name": "Giovanni Luca Beretta",
"url": "https://questionsmedicales.fr/author/Giovanni%20Luca%20Beretta",
"affiliation": {
"@type": "Organization",
"name": "Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Tumori, Via Amadeo 42, 20133 Milan, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Validity of the revised Diagnostic and Statistical Manual of Mental Disorders-5 cross-cutting symptom measure as implemented in community mental health settings.",
"datePublished": "2023-10-14",
"url": "https://questionsmedicales.fr/article/37844781",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jad.2023.10.077"
}
},
{
"@type": "ScholarlyArticle",
"name": "Interrater reliability of criterion A of the alternative model for personality disorder (Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition-Section III): A meta-analysis.",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37227864",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/per0000631"
}
},
{
"@type": "ScholarlyArticle",
"name": "Item Response Theory Analyses of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Criteria Adapted to Screen Use Disorder: Exploratory Survey.",
"datePublished": "2022-07-27",
"url": "https://questionsmedicales.fr/article/35896018",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/31803"
}
},
{
"@type": "ScholarlyArticle",
"name": "Psychopathy and antisocial personality disorder in the fifth edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders: An attempted replication of Wygant et al. (2016).",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37227862",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/per0000626"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functional impairment, insight, and comparison between criteria for gaming disorder in the International Classification of Diseases, 11 Edition and internet gaming disorder in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.",
"datePublished": "2022-11-02",
"url": "https://questionsmedicales.fr/article/36326855",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1556/2006.2022.00079"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Benzofuranes",
"item": "https://questionsmedicales.fr/mesh/D001572"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Benzofuranes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Benzofuranes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Benzofuranes",
"description": "Comment diagnostiquer une intoxication aux benzofuranes ?\nQuels tests sont utilisés pour détecter les benzofuranes ?\nQuels symptômes indiquent une exposition aux benzofuranes ?\nLes benzofuranes sont-ils visibles sur des tests standards ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Benzofuranes",
"description": "Quels sont les symptômes courants des benzofuranes ?\nLes benzofuranes provoquent-ils des effets psychologiques ?\nY a-t-il des symptômes cutanés associés aux benzofuranes ?\nLes benzofuranes affectent-ils le système respiratoire ?\nLes symptômes varient-ils selon la dose de benzofuranes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Benzofuranes",
"description": "Comment prévenir l'exposition aux benzofuranes ?\nLes travailleurs doivent-ils être formés sur les benzofuranes ?\nQuelles mesures de sécurité sont recommandées en laboratoire ?\nLes benzofuranes sont-ils réglementés ?\nComment gérer les déchets contenant des benzofuranes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Benzofuranes",
"description": "Quel traitement est recommandé pour l'intoxication aux benzofuranes ?\nDes antidotes existent-ils pour les benzofuranes ?\nComment traiter les symptômes neurologiques causés par les benzofuranes ?\nLes soins d'urgence sont-ils nécessaires pour l'exposition aux benzofuranes ?\nLa décontamination est-elle nécessaire après exposition ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Benzofuranes",
"description": "Quelles complications peuvent survenir après exposition aux benzofuranes ?\nLes benzofuranes peuvent-ils causer des maladies chroniques ?\nY a-t-il des effets à long terme des benzofuranes ?\nLes benzofuranes peuvent-ils affecter la reproduction ?\nComment surveiller les complications liées aux benzofuranes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Benzofuranes",
"description": "Qui est à risque d'exposition aux benzofuranes ?\nLes benzofuranes sont-ils présents dans des produits courants ?\nL'âge influence-t-il la sensibilité aux benzofuranes ?\nLes antécédents médicaux augmentent-ils le risque ?\nLes benzofuranes affectent-ils différemment les sexes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux benzofuranes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et les tests toxicologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les benzofuranes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter ces composés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition aux benzofuranes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles neurologiques, des nausées et des palpitations."
}
},
{
"@type": "Question",
"name": "Les benzofuranes sont-ils visibles sur des tests standards ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, des tests spécifiques sont nécessaires pour détecter les benzofuranes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à établir un lien entre les symptômes et l'exposition aux benzofuranes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des benzofuranes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des vertiges, des maux de tête et des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Les benzofuranes provoquent-ils des effets psychologiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent causer de l'anxiété, des hallucinations et des troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés aux benzofuranes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées et des démangeaisons peuvent survenir après exposition."
}
},
{
"@type": "Question",
"name": "Les benzofuranes affectent-ils le système respiratoire ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent provoquer des difficultés respiratoires et une irritation des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la dose de benzofuranes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux benzofuranes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection et suivre les protocoles de sécurité en laboratoire."
}
},
{
"@type": "Question",
"name": "Les travailleurs doivent-ils être formés sur les benzofuranes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité sont recommandées en laboratoire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des hottes, des gants et des lunettes de protection lors de la manipulation."
}
},
{
"@type": "Question",
"name": "Les benzofuranes sont-ils réglementés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur utilisation est souvent réglementée en raison de leur toxicité potentielle."
}
},
{
"@type": "Question",
"name": "Comment gérer les déchets contenant des benzofuranes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les déchets doivent être éliminés selon les protocoles de gestion des déchets dangereux."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé pour l'intoxication aux benzofuranes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend l'élimination de l'exposition et des soins symptomatiques."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les benzofuranes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas d'antidote spécifique pour les benzofuranes."
}
},
{
"@type": "Question",
"name": "Comment traiter les symptômes neurologiques causés par les benzofuranes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour gérer les symptômes neurologiques."
}
},
{
"@type": "Question",
"name": "Les soins d'urgence sont-ils nécessaires pour l'exposition aux benzofuranes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins d'urgence peuvent être nécessaires en cas d'exposition sévère."
}
},
{
"@type": "Question",
"name": "La décontamination est-elle nécessaire après exposition ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la décontamination est essentielle pour réduire l'absorption des benzofuranes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition aux benzofuranes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques, respiratoires et dermatologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les benzofuranes peuvent-ils causer des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut augmenter le risque de maladies chroniques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme des benzofuranes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets à long terme incluent des troubles cognitifs et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Les benzofuranes peuvent-ils affecter la reproduction ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent qu'ils peuvent avoir des effets néfastes sur la reproduction."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications liées aux benzofuranes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier est recommandé pour détecter les complications précoces."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'exposition aux benzofuranes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs en laboratoire et ceux manipulant des produits chimiques sont à risque."
}
},
{
"@type": "Question",
"name": "Les benzofuranes sont-ils présents dans des produits courants ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être présents dans certains produits chimiques et médicaments."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la sensibilité aux benzofuranes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées peuvent être plus sensibles."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires ou neurologiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les benzofuranes affectent-ils différemment les sexes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que les effets peuvent varier entre les sexes, mais les données sont limitées."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 01/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, Guizhou, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guizhou Medical University, Guiyang 550025, Guizhou, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Tumori, Via Amadeo 42, 20133 Milan, Italy.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, Via Celoria 2, 20133 Milan, Italy.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, Via Celoria 2, 20133 Milan, Italy.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Indian Institute of Technology Guwahati Assam 781039 India span@iitg.ac.in https://www.iitg.ac.in/span/.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Institute of Chemical Technology Mumbai IOC Odisha Campus Bhubaneswar Bhubaneswar 751013 India.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Institute of Chemical Technology Mumbai IOC Odisha Campus Bhubaneswar Bhubaneswar 751013 India.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Indian Institute of Technology Guwahati Assam 781039 India span@iitg.ac.in https://www.iitg.ac.in/span/.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangzhou 510006, China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangzhou 510006, China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangzhou 510006, China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Central laboratory, The NO.1 Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming 650021, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Institute of Organic Chemistry of Polish Academy of Sciences, Kasprzaka 44/52, 01-224, Warsaw, Poland.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Government College University Faisalabad, 38000 Faisalabad, Pakistan.
Publications dans "Benzofuranes" :
The purpose of this study was to validate the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) Cross-Cutting Symptom Measure (CCSM) as a screening tool for a wide variety of disorders w...
Participants (N = 851) were referred for coordinated specialty care services (mean age = 20.26 years (SD = 2.97); 82.5 % Caucasian, 7.5 % African American, 0.7 % Native American, 0.7 % Pacific Islande...
At optimal cut-score, specificity ranged from 57 to 77 % for depression, anxiety, substance use and psychosis domains; sensitivity ranged from 63 to 72 %. Scores for depression, anxiety, substance use...
Criterion measures did not have inter-rater reliabilities as this is generally prohibitive in clinic settings....
The CCSM could provide a first step in screening for multiple disorders; however, it cannot replace structured interviews for making diagnoses related to these conditions....
The alternative model for personality disorder (AMPD) is currently included in Section III of the Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition (DSM-5). This review sought to s...
Screen use is part of daily life worldwide and morbidity related to excess use of screens has been reported. Some use of screens in excess could indicate a screen use disorder (ScUD). An integrative a...
Our goals were (1) to describe screen uses in a general population sample and (2) to test the unidimensionality, local independence, and psychometric properties of the 9 Diagnostic and Statistical Man...
This cross-sectional survey in a French suburban city targeted adults and adolescents. A self-administered questionnaire covered the main types of screens used and their use for various activities in ...
Among the 300 participants, 171 (57.0%) were female (mean age 27 years), 297 (99.0%) used screens, 134 (44.7%) reported at least one criterion (potential problem users), and 5 (1.7%) reported 5 or mor...
We described screen uses in a French community sample and have shown that the adaptation of the DSM-5 IGD to "ScUD" has good psychometric validity and is discriminating, confirming our hypothesis. We ...
The fifth edition of the American Psychiatric Association's (APA)...
This study evaluated the consistency between the International Classification of Diseases, 11th Edition (ICD-11) for gaming disorder (ICD-11-GD) and Diagnostic and Statistical Manual of Mental Disorde...
We recruited 60 participants with GD, 45 participants who engaged in hazardous gaming (HG), and 120 controls based on a diagnostic interview. Their operationalization of functional impairment and stag...
We observed satisfactory consistency (kappa value = 0.80) with a diagnostic accuracy of 91.5% between the ICD-11-GD and DSM-5-IGD criteria. Furthermore, 16 participants with IGD in DSM-5 were determin...
There is a good consistency between ICD-11-GD and DSM-5-IGD criteria. The ICD-11 criteria have a high threshold for diagnosing GD. HG criteria could compensate for this high threshold and identify ind...
The conceptual basis of psychopathology within cancer survivorship is critical, as the chosen conceptualisation informs assessment and explanatory models, as well as interventions and supportive care ...
Age-related psychometric differences in Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) opioid use disorder (OUD) diagnostic criteria have been hypothesized, but not been te...
People who participated in the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions III and reported past 12-month nonmedical use of prescription opioids were included. YAs were 1...
One in 5 people met the DSM-5 OUD diagnostic criteria for OUD within the past 12 months, with the most endorsed criteria being tolerance (17.96%). DIF was identified for 3 criteria, including (1) taki...
These findings suggest that there may be age-related variations in the DSM-5 OUD diagnostic criteria's ability to detect latent OUD. Future research should identify contributing factors and the influe...
There is a scarcity of summarizing data on the epidemiology of insomnia in older persons, especially when diagnosed with international criteria. This study aimed to estimate the prevalence and correla...
Through PubMed/MEDLINE, EMBASE, and Web of Science (WoS), we searched for relevant articles published before June 28, 2023. The risk of bias was weighed using the Joanna Briggs Institute's (JBI's) cri...
We included 18,270 participants across 16 studies. The male/female ratio was 0.89 (12 studies), and the mean age varied from 65.9 to 83.1 years (8 studies). The pooled prevalence of insomnia was 19.6%...
Nearly one in every five old individuals was considered to have insomnia disorder, which was associated with the gender and the existence of mental health and/or somatic conditions....
We registered the protocol in the International Prospective Register of Systematic Reviews (PROSPERO) with registration number: CRD42022344675....
The alternative model of personality disorders (AMPD) traits were designed to maintain continuity with the Section II personality disorder (PD) diagnoses by retaining the same clinical information. Wh...
The Impact of Event Scale-Revised (IES-R) is a widely used self-report for assessing posttraumatic stress disorder (PTSD), originally aligned with Diagnostic and Statistical Manual of Mental Disorders...
A total of 238 participants recruited from multiple psychiatric centers, including 67 patients with PTSD, 72 patients with psychiatric controls, and 99 healthy controls, were included in the study. Al...
The IES-R demonstrated good internal consistency and a high correlation with the PCL-5. Through factor analysis, 5 distinct dimensions emerged within the IES-R: sleep disturbance, intrusion, hyperarou...
These findings underscore the scale's concurrent validity with the DSM-5 PTSD criteria and its effectiveness as a screening tool. Implementing a cutoff score of 25 on the IES-R can enhance its utility...